AzTrials
AzTrials

Periodontal DiseasesNCT07856901

Retinal and Choroidal Changes in Periodontal Disease

An observational study of Periodontal Diseases and Periodontal Diseases Inflammation, run by Zeliha Başak Çakır Erdil at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Advanced PeriodontitisIn this cross-sectional study, the relationship between periodontal disease severity and retinal and choroidal structural changes was evaluated using SD-OCT. Data from a total of 80 participants were examined. Read more about this study

Who is it for?
Ages 20 to 54 yearsHealthy volunteers can take part
How many people
80 participants
Where
1 siteTurkey (Türkiye)
Study dates
Oct 2026to Oct 2026
How long will I take part?
1 Day
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 54 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: The study population consisted of 80 systemically healthy, non-smoking adults who underwent comprehensive periodontal examination and spectral-domain optical coherence tomography (SD-OCT). Participants were classified into four groups according to their periodontal status (periodontally healthy, gingivitis, early periodontitis, and advanced periodontitis). All participants provided written informed consent before enrollment.

Who may be able to join

  • Systemically healthy adults. Non-smokers (no current or previous tobacco use). Participants who underwent optical coherence tomography (OCT) imaging. Participants who provided written informed consent and agreed to participate in the study.

Who cannot join

  • Presence of any systemic disease. Current or former smokers. Participants with incomplete clinical or OCT data. Individuals who did not provide written informed consent.
  • -

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Zeliha B ÇAKIR ERDİL, DDS contact

+905059444038

bskcakirr@gmail.com

Metin Çalışır, Prof.DR contact

metincalisir@adiyaman.edu.tr

Turkey (Türkiye)1 site
  • Faculty of Dentistry, Adıyaman University

    Adıyaman, Adıyaman Province, 02030

    Zeliha B ERDİL, DDS, 05059444038, bskcakirr@gmail.com

Other trials in Turkey (Türkiye)

About this study

Official title: RETİNAL AND CHOROİDAL STRUCTURAL ALTERATİONS ACROSS THE PERİODONTAL DİSEASE CONTİNUUM: A CROSS-SECTİONAL OBSERVATİONAL STUDY

Advanced PeriodontitisIn this cross-sectional study, the relationship between periodontal disease severity and retinal and choroidal structural changes was evaluated using SD-OCT. Data from a total of 80 participants were examined. It was found that choroidal thickness increased and ganglion cell layer thickness decreased as periodontal disease severity increased, while no significant relationship was found in RNFL and IPL thicknesses. The findings support a possible association between periodontal disease and ocular structural changes.

Read the detailed description

Periodontal disease, by causing chronic inflammation, can affect not only oral tissues but also systemic organs. While the potential link between periodontal disease and eye diseases has attracted attention in recent years, data regarding retinal and choroidal structural changes are limited. In this study, periodontal clinical findings were compared with measurements of retinal nerve fiber layer (RNFL), ganglion cell layer (GCL), inner plexiform layer (IPL), and choroid thickness obtained using spectral-domain optical coherence tomography (SD-OCT) in a total of 80 individuals diagnosed with periodontal health, gingivitis, early periodontitis, and advanced periodontitis. The findings showed that choroidal thickness increased and GCL thickness decreased as the severity of periodontal disease increased. This study aims to contribute to a better understanding of the relationship between periodontal disease and ocular structural changes and to provide a basis for future prospective research.

Group 1: Periodontal Healthy

Participants with clinically healthy periodontal tissues and no evidence of gingivitis or periodontitis.

Group 2: Gingivitis

Participants diagnosed with gingivitis, presenting gingival inflammation without clinical attachment loss.

Group 3: Early Periodontitis

Participants diagnosed with early-stage periodontitis based on clinical periodontal examination.

Group 4: Advanced Periodontitis

Participants diagnosed with advanced periodontitis with greater periodontal tissue destruction.

Keywords
Retinal degeneration ; Tomography, Optical Coherence ; Periodontitis ; gingivitis; Retinal Ganglion Cells ; Periodontal Index
Medical subject headings
Periodontal Diseases, Retinal Degeneration, Periodontitis, Gingivitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07856901
Study groupRoleWhat they receive
Periodontal HealthyNot described
GingivitisNot described
Early PeriodontitisNot described
Advanced PeriodontitisNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Correlation Between Periodontal Disease Severity and Choroidal Thickness

    The correlation between periodontal disease severity and choroidal thickness will be assessed using Spearman's correlation coefficient (rₛ). Periodontal disease severity will be assessed using probing pocket depth (PPD) and clinical attachment level (CAL), measured in millimeters (mm) using a periodontal probe. Choroidal thickness will be measured in micrometers (µm) using spectral-domain optical coherence tomography (SD-OCT).

    Measured: Baseline

Secondary outcomes (3)
  1. Correlation Between Periodontal Disease Severity and Retinal Nerve Fiber Layer (RNFL) Thickness

    The correlation between periodontal disease severity and retinal nerve fiber layer (RNFL) thickness will be evaluated. Periodontal disease severity will be assessed using clinical periodontal parameters, including probing pocket depth (PPD) and clinical attachment level (CAL), measured in millimeters (mm). RNFL thickness will be measured in micrometers (µm) using spectral-domain optical coherence tomography (SD-OCT). The correlation will be quantified using Spearman's correlation coefficient (rₛ).

    Measured: Baseline

  2. Correlation Between Periodontal Disease Severity and Ganglion Cell Layer (GCL) Thickness

    The correlation between periodontal disease severity and ganglion cell layer (GCL) thickness will be evaluated. Periodontal disease severity will be assessed using clinical periodontal parameters, including probing pocket depth (PPD) and clinical attachment level (CAL), measured in millimeters (mm). GCL thickness will be measured in micrometers (µm) using spectral-domain optical coherence tomography (SD-OCT). The correlation will be quantified using Spearman's correlation coefficient (rₛ).

    Measured: Baseline

  3. Correlation Between Periodontal Disease Severity and Inner Plexiform Layer (IPL) Thickness

    The correlation between periodontal disease severity and inner plexiform layer (IPL) thickness will be evaluated. Periodontal disease severity will be assessed using clinical periodontal parameters, including probing pocket depth (PPD) and clinical attachment level (CAL), measured in millimeters (mm). IPL thickness will be measured in micrometers (µm) using spectral-domain optical coherence tomography (SD-OCT). The correlation will be quantified using Spearman's correlation coefficient (rₛ).

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Oct 2026
  2. Study startOct 2026 (estimated)
  3. Primary completionOct 2026 (estimated)
  4. Study completionOct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
80 participants (estimated)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT07856901
Sponsor's protocol ID
HÜ-KAEK-2026-00255
Status last verified
Sep 2026
First submitted
22 Jul 2026
Last updated
5 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared to protect participant confidentiality and privacy.

Questions about this trial

What is this clinical trial studying?

An observational study of Periodontal Diseases and Periodontal Diseases Inflammation, run by Zeliha Başak Çakır Erdil at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 5 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Zeliha B ÇAKIR ERDİL, DDS (+905059444038, bskcakirr@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Correlation Between Periodontal Disease Severity and Choroidal Thickness (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in